Peptide University · Module 5 · Lesson 4 of 4

IGF-1, its binding proteins and its variants

The somatotropic axis: growth hormone secretagogues

Reading time: ~2 min · Part of the free certification in peptide science

Most of the anabolic effects attributed to growth hormone are not produced by GH directly but by IGF-1, synthesized mainly in the liver under GH stimulation. Understanding IGF-1 is understanding half of the somatotropic axis.

The IGF system

  • IGF-1: a 70-amino-acid peptide with structural homology to proinsulin. It acts on the IGF-1R receptor (tyrosine kinase) and, with lower affinity, on the insulin receptor.
  • IGFBP (binding proteins, 1 to 6): in plasma, almost all IGF-1 circulates bound to them, mainly in a ternary complex with IGFBP-3 and the acid-labile subunit. Only the free fraction is active.
  • Feedback: IGF-1 inhibits GH secretion in the pituitary and stimulates somatostatin secretion in the hypothalamus.

IGF-1 LR3

It is a variant with a 13-amino-acid extension at the N-terminus and a Glu to Arg substitution at position 3. The result is a greatly reduced affinity for IGFBPs: a larger free fraction and a half-life much longer than native IGF-1's. That same property means its activity is not «buffered» by the binding protein system.

MGF (mechano growth factor)

It is an alternative splicing product of the IGF-1 gene (the IGF-1Ec variant in humans) expressed in muscle after mechanical stimulus. The peptide studied corresponds to its C-terminus (E peptide). The literature is mostly preclinical with heterogeneous results; its natural half-life is very short, which motivated the PEGylated version.

Safety considerations specific to the axis

  • Hypoglycemia: because of their action on the insulin receptor, IGF-1 and its analogs can lower blood glucose. It is the most relevant acute effect.
  • Cell proliferation: IGF-1R is a mitogenic and anti-apoptotic pathway. That is why active neoplasia is a recurring contraindication across the entire GH/IGF-1 axis, including approved drugs.
📊 Reference marker

In clinical practice, serum IGF-1 is the integrated marker of GH activity, because GH is pulsatile and a single measurement says little. Secretagogue studies use it as the primary endpoint for the same reason.

Catalogue compounds mentioned in this lesson

Take the module 5 quiz and earn your certificate

The certification is free: read the lessons, pass each module quiz and the final exam, and download your PDF certificate with a verifiable ID.

Go to the quiz →

Educational content for scientific purposes. It distinguishes preclinical from clinical evidence and is not medical advice, diagnosis or a recommendation for use. NeoPeptidos products are sold labelled for research use only (RUO).